4//SEC Filing
SYNTA PHARMACEUTICALS CORP 4
Accession 0001179110-15-013897
$MDGLCIK 0001157601operating
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 5:33 PM ET
Size
5.1 KB
Accession
0001179110-15-013897
Insider Transaction Report
Form 4
Vukovic Vojo
SVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-10-02+132,300→ 132,300 totalExercise: $1.76Exp: 2025-10-02→ Common Stock (132,300 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on October 2, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 5:33 PM ET
- Size
- 5.1 KB